title: Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: a dose response assay.
abstract: Twenty-one dogs with spontaneously occurring appendicular osteosarcoma were given preoperative radiation therapy prior to a limb sparing procedure using a cortical allograft. Radiation doses were randomly assigned, ranged from 36-52 Gy in 4 Gy intervals, and were given in 10 equally-sized fractions on a M, W, F schedule. Seventeen of the 21 dogs underwent the limb sparing procedure approximately 3 weeks after completion of radiation therapy. Local tumor recurrence was documented in 4 of 17 dogs at mean and median times of 5.5 and 5.8 months, respectively, after initiation of radiation therapy. Three of 4 recurrences were in anatomic regions with sparse adjacent soft tissue which precluded wide excision. Complications were significant. Fixation device failure occurred in 9 of 17 dogs and was associated with host bone necrosis, muscle thinning and fibrosis of vessels and nerves in irradiated normal tissue. Incidence of host bone necrosis was directly related to radiation dose (Kendall's statistic, p = 0.005). Metastasis occurred in all 21 dogs. Mean and median times to metastasis in these dogs were 5.1 and 4.0 months, respectively, after initiation of radiation therapy. Local tumor control rates and survival times were higher in dogs developing allograft infection suggesting that infection acted as an immunostimulant. All local failures occurred in dogs that did not develop allograft infection and median survival times for uninfected versus infected dogs were 5 and 11 months, respectively (logrank test, p = 0.029). Increased tumor radiopacity following radiation therapy was significantly related to survival. Median survival in dogs whose tumors were characterized by decreased, unchanged or increased opacity after radiation therapy were 3.5 and 14 months, respectively (logrank test, p = 0.014). Based on the results of our study, radiation therapy can not be recommended as part of limb sparing treatments for patients with osteosarcoma at doses and dose per fraction values similar to those used herein.
authors.affiliation: College of Veterinary Medicine, North Carolina State University, Raleigh 27606.
authors.forename: D E
authors.initials: DE
authors.lastname: Thrall
authors.forename: S J
authors.initials: SJ
authors.lastname: Withrow
authors.forename: B E
authors.initials: BE
authors.lastname: Powers
authors.forename: R C
authors.initials: RC
authors.lastname: Straw
authors.forename: R L
authors.initials: RL
authors.lastname: Page
authors.forename: G L
authors.initials: GL
authors.lastname: Heidner
authors.forename: D C
authors.initials: DC
authors.lastname: Richardson
authors.forename: K W
authors.initials: KW
authors.lastname: Bissonnette
authors.forename: C W
authors.initials: CW
authors.lastname: Betts
authors.forename: D J
authors.initials: DJ
authors.lastname: DeYoung
mesh_terms: D000818:Animals; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D016025:Bone Transplantation; D003131:Combined Modality Therapy; D004285:Dogs; D004307:Dose-Response Relationship, Radiation; D005121:Extremities / Q000528:radiation effects / Q000601:surgery*; D012516:Osteosarcoma / Q000532:radiotherapy / Q000601:surgery*; D011300:Preoperative Care